Stroke education goes High-Tech: personalized videos aim to boost recovery

NCT ID NCT06442631

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tests whether a personalized video platform called MyStroke can improve stroke knowledge and reduce hospital use after discharge. About 690 stroke patients and their caregivers will either get standard education or also access to tailored videos. Researchers will check knowledge at 90 days and track how often people return to the hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
personalized video-based education platform
What this could lead to
If successful, this could show that tailored video education helps stroke survivors and caregivers better understand their condition and may reduce unnecessary hospital visits.
What could go wrong
This is an early-stage behavioral study, not a drug trial. The effect on health outcomes may be small, and results may not apply to all stroke patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE, ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chester County Hospital

    West Chester, Pennsylvania, 19380, United States

  • Lancaster General Hospital

    Lancaster, Pennsylvania, 17602, United States

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania, 19104, United States

  • Pennsylvania Hospital

    Philadelphia, Pennsylvania, 19107, United States

  • The Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.